1,004
Views
74
CrossRef citations to date
0
Altmetric
Review Article

Generation of data on within-subject biological variation in laboratory medicine: An update

&
Pages 313-325 | Received 09 Oct 2015, Accepted 01 Feb 2016, Published online: 14 Mar 2016

References

  • Fraser CG. Biological Variation: from Principles to Practice. Washington (DC): AACC Press, 2001: 9–18
  • Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409–37
  • Braga F, Panteghini M. Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies. Clin Chim Acta 2014;432:55–61
  • Fraser CG, Kallner A, Kenny D, et al. Strategies to set global analytical quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999;59:475–585
  • Panteghini M, Sandberg S. Defining analytical performance specifications 15 years after the Stockholm conference. Clin Chem Lab Med 2015;53:829–32
  • Sandberg S, Fraser C, Horvath AR, et al. Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53:833–5
  • Klee GG. Establishment of outcome-related analytic performance goals. Clin Chem 2010;56:714–22
  • Fraser CG, Hyltoft Peterson P, Libeer JC, et al. Proposal for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8–12
  • Oosterhuis WP. Gross overestimation of total allowable error based on biological variation. Clin Chem 2011;57:1334–6
  • Desirable Biological Variation Database Specifications. Available from: www.westgard.com/biodatabase1.htm [last accessed 14 Jan 2016]
  • Fraser CG, Hyltoft Peterson P, Larsen ML. Setting analytical goals for random analytical error in specific clinical monitoring situations. Clin Chem 1990;36:1625–8
  • Horowitz GL, Altaie S, Boyd JC, et al. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline – third edition CLSI document C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008
  • Harris EK. Statistical aspect of reference values in clinical pathology. Prog Clin Pathol 1981;8:45–66
  • Fraser CG. Making better use of differences in serial laboratory results. Ann Clin Biochem 2012;49:1–3
  • Fraser CG. Reference change values. Clin Chem Lab Med 2012;50:807–12
  • Harris EK, Yasaka T. On the calculation of a “reference change” for comparing two consecutive measurements. Clin Chem 1983;29:25–30
  • Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009;46:8–17
  • Braga F, Ferraro S, Szöke D, et al. Estimate of intraindividual variability of C-reactive protein: a challenging issue. Clin Chim Acta 2013;419:85–6
  • Braga F, Ferraro S, Ieva F, et al. A new robust statistical model for interpretation of differences in serial test results from an individual. Clin Chem Lab Med 2015;53:815–22
  • Miller WG, Bruns DE, Hortin GL, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009;55:24–38
  • Braga F, Dolci A, Mosca A, et al. Biological variation of glycated hemoglobin. Clin Chim Acta 2010;411:1006–10
  • Braga F, Panteghini M. Biologic variability of C-reactive protein: is the available information reliable? Clin Chim Acta 2012;413:1179–83
  • Carobene A, Braga F, Roraas T, et al. A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase. Clin Chem Lab Med 2013;51:1997–2007
  • Bartlett WA, Braga F, Carobene A, et al. A checklist for critical appraisal of studies of biological variation. Clin Chem Lab Med 2015;53:879–85
  • STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. Available from: http://www.stard-statement.org. [last accessed 16 Jan 2016]
  • Ricós C1, Iglesias N, García-Lario JV, et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007;44:343–52
  • Lawson N. Is variation in biological variation a problem? Ann Clin Biochem 2007;44:319–20
  • Fraser CG. Improved monitoring of differences in serial laboratory results. Clin Chem 2011;57:1635–7
  • Fraser C, Cummings ST, Wilkinson SP, et al. Biological variability of 26 clinical chemistry analytes in elderly people. Clin Chem 1989;35:783–6
  • Carobene A, Graziani MS, Lo Cascio C, et al. Age dependence of within-subject biological variation of nine common clinical chemistry analytes. Clin Chem Lab Med 2012;50:841–4
  • Braga F, Ferraro S, Mozzi R, et al. The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer. Clin Chem Lab Med 2014;52:1625–31
  • Gowans EM, Fraser CG. Longer-term biological variation of commonly analyzed serum constituents. Clin Chem 1987;33:717
  • Lippi G, Mattiuzzi C, Banfi G. Proposta di una “checklist” per il prelievo di sangue venoso. Biochim Clin 2013;37:312–17
  • Lippi G, Caputo M, Banfi G, et al. Giavarina D per il Gruppo di Studio Intersocietario SIBioC-SIMeL-CISMEL sulla Variabilità Extra-Analitica del Dato di Laboratorio. Raccomandazioni per il prelievo di sangue venoso. Biochim Clin 2008;32:569–77
  • Panteghini M, Pagani F. On the comparison of serum and plasma samples in troponin assays. Clin Chem 2003;49:835–6
  • Jones GRD, Panteghini M. Pre-analytical factors affecting troponin measurement. In: Tate J, Johnson R, Jaffe A, Panteghini M, ed. Laboratory and Clinical Issues Affecting the Measurement and Reporting of Cardiac Troponin: A Guide for Clinical Laboratories. Alexandria, NSW, Australia: The Australasian Association of Clinical Biochemists, 2012:63–7
  • Braga F, Ferraro S, Mozzi R, et al. Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase. Clin Biochem 2013;46:148–51
  • Panteghini M, Pagani F. Biological variation in bone-derived biochemical markers in serum. Scand J Clin Lab Invest 1995;55:609–16
  • Pagani F, Panteghini M. Significance of various parameters derived from biological variability for lipid and lipoprotein analyses. Clin Biochem 1993;26:415–20
  • Garde AH, Hansen AM, Skovgaard LT, et al. Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A1c, IgA, prolactin, and free testosterone in healthy women. Clin Chem 2000;46:551–9
  • Panteghini M. Traceability, reference systems and result comparability. Clin Biochem Rev 2007;28:97–104
  • Braga F, Panteghini M. Standardization and analytical goals for glycated hemoglobin measurement. Clin Chem Lab Med 2013;51:1719–26
  • Braga F, Dolci A, Montagnana M, et al. Revaluation of biological variation of glycated hemoglobin (HbA1c) using an accurately designed protocol and an assay traceable to the IFCC reference system. Clin Chim Acta 2011;412:1412–16
  • Carobene A, Ceriotti F, Infusino I, et al. Evaluation of the impact of standardization process on the quality of serum creatinine determination in Italian laboratories. Clin Clin Acta 2014;427:100–6
  • Panteghini M. Enzymatic assays for creatinine: time for action. Clin Chem Lab Med 2008;46:567–72
  • Panteghini M. Quality requirements for troponin assays – An overview. In: Troponin Monograph 2012. Alexandria, NSW, Australia: The Australasian Association of Clinical Biochemists Inc., 2012:53–61
  • Vasile VC, Saenger AK, Kroning JM, et al. Procalcitonin in healthy individuals. Electronic letter to Barassi A, Pallotti F, d Eril GM. Biological variation of procalcitonin in healthy individuals. Clin Chem 2004;50:1086. Available at: http://www.zoominfo.com/CachedPage/?archive_id=0&page_id=857341327&page_url=//www.clinchem.org/cgi/eletters/50/10/1878&page_last_updated=2004-10-11T03:42:47&firstName=Nils&lastName=Morgenthaler
  • Frankenstein L, Wu AH, Hallermayer K, et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem 2011;57:1068–71
  • Nils GM, Struck J, Bergmann A. Procalcitonin in healthy individuals. Electronic letter to Barassi A, Pallotti F, d'Eril GM. Biological variation of procalcitonin in healthy individuals. Clin Chem 2004;50:1878.Available at: http://www.zoominfo.com/CachedPage/?archive_id=0&page_id=857341327&page_url=//www.clinchem.org/cgi/eletters/50/10/1878&page_last_updated=2004-10-11T03:42:47&firstName=Nils&lastName=Morgenthaler
  • Young DS, Harris EK, Cotlove E. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. IV. Results of a study designed to eliminate long-term analytic deviations. Clin Chem 1971;17:403–10
  • Braga F, Infusino I, Panteghini M. Performance criteria for combined uncertainty budget in the implementation of metrological traceability. Clin Chem Lab Med 2015;53:905–12
  • Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591–611
  • Daniel WW. Kolmogorov–Smirnov one-sample test. In: Daniel WW, ed. Applied Nonparametric Statistics. 2nd ed. Boston (MA): Cengage, 1990:319–30
  • Fay MP, Proschan MA. Wilcoxon–Mann–Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat Surv 2010;4:1–39. doi: 10.1214/09-SS051
  • Snedecor GW, Cochran WG. Statistical Methods. 8th ed. Iowa State University Press, 1989
  • Cochran WG. The distribution of the largest of a set of estimated variances as a fraction of their total. Ann Hum Genet 1941;11:47–52
  • Levene H. Robust tests for equality of variances In: Olkin I et al, eds. Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling. Stanford University Press, 1960;278–92
  • Brown MB, Forsythe AB. Robust tests for equality of variances. J Amer Statist Assoc 1974;69:364–7
  • Conover WJ, Johnson ME, Johnson MM. A comparative study of tests for homogeneity of variances, with applications to the outer continental shelf bidding data. Technometrics 1981;23:351–61
  • Roraas T, Petersen PH, Sandberg S. Confidence intervals and power calculations for within-subject biological variation: effect of analytical variation, number of replicates, number of samples and number of individuals. Clin Chem 2012;58:1306–13
  • Simundic AM, Kackov S, Miler M, et al. Terms and symbols used on studies of biological variation: the need for harmonisation. Clin Chem 2015;61:438–9
  • Perich C, Minchinela J, Ricós C, et al. Biological variation database: structure and criteria used for generation and update. Clin Chem Lab Med 2015;53:299–305
  • Topic E, Nikolac N, Panteghini M, et al. How to assess the quality of your analytical method? Clin Chem Lab Med 2015;53:1707–18
  • DeGoma EM, French B, Dunbar RL, et al. Intraindividual variability of C- reactive protein: the multi-ethnic study of atherosclerosis. Atherosclerosis 2012;224:274–9
  • Glynn RDJ, MacFadyen JG, Ridker PM. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. Clin Chem 2009;55:305–12
  • Campbell B, Badrick T, Flatman R, et al. Limited clinical utility of high-sensitivity plasma C-reactive protein assays. Ann Clin Biochem 2002;39:85–8
  • Ferraro S, Braga F, Lanzoni M, et al. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review. J Clin Pathol 2013;66:273–81
  • Ferraro S, Schiumarini D, Panteghini M. Human epididymis protein 4: factors of variation. Clin Chim Acta 2015;438:171–7
  • Anastasi E, Granato T, Marchei GG, et al. Ovarian tumor marker HE4 is differently expressed during the phase of menstrual cycle in healthy young women. Tumor Biol 2010;31:411–15
  • Ferraro S, Borille S, Caruso S, et al. Body mass index does not influence human hepididymis protein 4 concentrations in serum. Clin Chim Acta 2015;446:163–4
  • Ridker PM, Rifai N. C-reactive protein in the primary prevention of myocardial infarction and stroke. In: Ridker PM, Rifai N eds. C-reactive protein and cardiovascular disease. St-Laurent (QC): MediEdition, 2006:1–23
  • Chiriboga DE, Ma Y, Li W, et al. Seasonal and sex variation of high-sensitivity C reactive protein in healthy adults: a longitudinal study. Clin Chem 2009;55:313–21
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33:S62–9
  • Hoelzel W, Miedema K. Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem 1996;9:62–7
  • Weykamp C, John WG, Mosca A, et al. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem 2008;54:240–8
  • Little RR, Rohlfing CL, Sacks DB. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011;57:205–14
  • Panteghini M, John WG. Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward. Clin Chem Lab Med 2007;45:942–4
  • Hoelzel W, Weykamp C, Jeppsson J, et al. Wiedmeyer HM on behalf of the IFCC Working Group on HbA1c Standardization IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004;50:166–74
  • Weykamp CW, Mosca A, Gillery P, et al. The analytical goals for hemoglobin A1c measurement in IFCC units and National Glycohemoglobin Standardization Program units are different. Clin Chem 2011;57:1204–6
  • Braga F, Infusino I, Dolci A, et al. Biological variation of free light chains in serum. Clin Chim Acta 2013;415:10–11
  • ’t Lam RU. Scrutiny of variance results for outliers: Cochran’s test optimized. Anal Chim Acta 2010;659:68–84
  • Braga F, Szőke D, Valente C, et al. Biologic variation of copper, ceruloplasmin and copper/ceruloplasmin ratio (Cu:Cp) in serum. Clin Chim Acta 2013;415:295–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.